What's New in Health and Life Sciences
News from the European Commission
EUROPA - Research and Innovation: What's New in Health and life sciences
EUROPA - Research What's New in Health and life sciences. This RSS feed includes the most recent updates to the European Commission's Research and Innovation web site on Europa in the area of Health and life sciences. The last (or, in some news readers, the first) item of this feed will take you to the Health web site. For more RSS news feeds visit http://ec.europa.eu/research/index.cfm?pg=rss
For more RSS news feeds click the link above.
Monoclonal antibodies have emerged as a powerful weapon in the fight against a variety of diseases, including several types of cancer - but producing them remains a costly process. Crystallisation is the way forward, say EU-funded researchers working on an innovation that could make it easier, greener and far more affordable.
Roughly 151 million people worldwide suffer from osteoarthritis, meaning that they experience chronic pain, reduced mobility and limited quality of life. Attempts to repair cartilage thus far have offered limited functionality and only temporary pain reduction. The usual course of action is therefore to replace the entire joint, rather than repair the damaged cartilage. A team of researchers from the EU and Australia is however working on a promising alternative in which 3D printing plays a key role.
Magnetic Resonance Imaging or MRI is a routine medical technique used to form pictures of the inner workings of the body for diagnosis. An EU-funded project seeks to massively boost the information MRI can deliver to doctors - potentially helping them to better diagnose and treat patients.
A huge amount of biological knowledge and clinical data is incrementally generated, but this wealth of information is not fully exploited - while bioinformatics tools exist, they are currently underused. EU-funded researchers are now developing applications that will make it easier for translational scientists to access the data and use it for research that will improve healthcare.
Tuberculosis (TB) and tobacco-related lung disease kill millions around the world every year. What if programmes to stop one could target the other, too? An international initiative, including partners from Pakistan, Bangladesh and Nepal is doing just that, blending effective yet affordable tobacco cessation strategies with TB control programmes.
Abnormal heart rhythm is a major cause of cardiovascular disease and death in Europe. An EU-supported programme has made several advances in wearable technology to more comfortably monitor the heart over longer periods, in the hope of saving lives and cutting treatment costs.
EU-funded researchers have analysed the efficacy and required dosage of several antibiotics licensed decades ago. Their findings could enable doctors to prescribe certain drugs with greater confidence and strengthen EU efforts to tackle the growing problem of drug resistance.
Management and treatment of neurological diseases is one of the biggest challenges facing medicine today. EU-funded researchers are developing computational tools to improve understanding of how such diseases progress as a means to help treat patients.
An EU-funded project aims to identify and maximise the potential of novel vaccines to end the global tuberculosis epidemic. These could save lives, stem the spread of infection and shorten treatment for the often deadly, airborne disease.